Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 173 | 308 | 10 | 14 | 127 |
| Receivables | 4 | 10 | N/A | 5 | 6 |
| TOTAL | $327 | $528 | $77 | $33 | $170 |
| Non-Current Assets | |||||
| PPE Net | 11 | 13 | 13 | 9 | 9 |
| Other Non-Current Assets | 271 | 21 | 21 | 21 | 21 |
| TOTAL | $282 | $34 | $34 | $30 | $30 |
| Total Assets | $610 | $562 | $110 | $62 | $201 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 623 | 590 | 480 | 442 | 433 |
| Other current liabilities | N/A | N/A | N/A | 1 | 0 |
| TOTAL | $2,840 | $2,184 | $1,458 | $991 | $930 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 761 | 715 |
| Deferred Revenues | 293 | 287 | 261 | 194 | 190 |
| Other Non-Current Liabilities | 60 | 33 | 13 | 11 | 12 |
| TOTAL | $1,690 | $1,727 | $1,764 | $1,915 | $1,908 |
| Total Liabilities | $4,530 | $3,911 | $3,222 | $2,906 | $2,837 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 23,694 | 23,694 | 1,046 | 22,834 | 22,834 |
| Common Shares | 40,969 | 40,877 | 40,704 | 40,579 | 40,574 |
| Retained earnings | -44,983 | -44,321 | -43,845 | -43,518 | -43,304 |
| TOTAL | $-3,921 | $-3,350 | $-3,046 | $-2,844 | $-2,637 |
| Total Liabilities And Equity | $610 | $562 | $175 | $62 | $201 |